P. Garred et al., DEPOSITION OF C3, THE TERMINAL COMPLEMENT COMPLEX AND VITRONECTIN IN PRIMARY BILIARY-CIRRHOSIS AND PRIMARY SCLEROSING CHOLANGITIS, Liver, 13(6), 1993, pp. 305-310
Characteristics of primary biliary cirrhosis (PBC) and primary scleros
ing cholangitis (PSC) are bile duct destruction and portal inflammatio
n. Increased levels of circulating complement activation products are
also present. This raises the possibility of involvement of complement
-dependent cytotoxic mechanisms in the pathogenesis. Therefore, we inv
estigated liver biopsy specimens from 21 patients with PBC, six patien
ts with PSC and six controls for complement deposits by immunohistoche
mistry using polyclonal and monoclonal antibodies against C3d, the ter
minal complement complex (TCC) and vitronectin (S-protein). We found C
3d, TCC and vitronectin deposits only in the portal tracts. C3d and TC
C were present in the walls of the hepatic arteries and in the connect
ive tissue stroma but never around the bile ducts. We found vitronecti
n deposits throughout the connective tissue, often independent of the
TCC deposits. When vitronectin and TCC were co-localized, the staining
patterns were inverse: that is, intense staining for TCC accompanied
weak staining for vitronectin and vice versa. Occasionally complete di
ssociation between TCC and vitronectin staining was observed. Deposits
of TCC and vitronectin showed a focal distribution leaving many porta
l tracts free of TCC. Our results question whether complement-dependen
t cytotoxic mechanisms take part in the bile duct destruction in PBC a
nd PSC.